Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919117 | Radiotherapy and Oncology | 2013 | 5 Pages |
Abstract
I-125 prostate brachytherapy results in excellent 7-year BFFS, CSS, and OS for low-risk and low-tier intermediate-risk prostate cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Toshio Ohashi, Atsunori Yorozu, Shiro Saito, Tetsuo Momma, Kazuhito Toya, Toru Nishiyama, Shoji Yamashita, Yutaka Shiraishi, Naoyuki Shigematsu,